Skip to content

New Dimension in Chromatography - Halo® 1.5

LC-MS Analysis of Trastuzumab Using HALO® 1000 Å C4

lc-ms analysis of trastuzumab using halo 1000

Bonded Phase: C4

Market Segment: Biopharmaceuticals

Particle Size: 2.7 µm

Pore Size: 1000 Å

Product Segment: BIOCLASS

Separation Mode: Reversed Phase

USP Number: L26

Download File
Back To Top